Search Within

Ahmet Dogan

Formats
  1. Meeting Abstract (242)
  2. Journal Article (166)
  3. Research Letter (20)
  4. Review (16)
  5. Book Section (14)
  6. Guidelines (5)
  7. Editorial (4)
  8. Correspondence (2)
  9. Miscellaneous (1)
Groups
  1. Department of Pathology and Laboratory Medicine (470)
  2. Department of Medicine (315)
  3. Hematologic Malignancies, Division of (313)
  4. Center for Hematologic Malignancies (307)
  5. Sloan Kettering Institute Postdocs (180)
  6. Lymphoma (171)

More Groups

People
  1. Steven Horwitz (101)
  2. Mikhail Roshal (98)
  3. Maria Arcila (91)
  4. Andrew Zelenetz (81)
  5. Alison Moskowitz (78)
  6. Anita Kumar (64)

More People

Years
  1. 2025 (17)
  2. 2024 (47)
  3. 2023 (56)
  4. 2022 (33)
  5. 2021 (38)
  6. 2020 (59)

More Years

Publications
  1. Blood (135)
  2. Laboratory Investigation (47)
  3. Modern Pathology (36)
  4. Journal of Clinical Oncology (15)
  5. Haematologica (14)
  6. Journal of Molecular Diagnostics (14)

More Publications

Publishers
  1. American Society of Hematology (147)
  2. Nature Publishing Group (74)
  3. Nature Research (38)
  4. Wiley Blackwell (27)
  5. American Society of Clinical Oncology (19)
  6. Elsevier Inc. (17)

More Publishers

Results (470)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Aberrant SYK expression as a potential therapeutic target in T/NK cell neoplasms
    Meeting Abstract

    Zhang, J. P.; Gao, Q.; Chan, A.; Xiao, W.; El Daker, S.; Roshal, M.; Dogan, A.
    Blood (2019)

    Fulltext@MSK | Save
  • Annotation of somatic genomic variants in hematologic diseases using OncoKB, a precision oncology knowledgebase
    Meeting Abstract

    Suehnholz, S. P.; Kundra, R.; Roshal, M.; Xiao, W.; Petrova-Drus, K.; Yabe, M.; Ho, C.; Zhang, H.; Knorr, D.; Miles, L. A.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • Final results of a phase II biomarker-driven study of ruxolitinib in relapsed and refractory T-cell lymphoma
    Meeting Abstract

    Moskowitz, A. J.; Ghione, P.; Jacobsen, E. D.; Ruan, J.; Schatz, J. H.; Noor, S.; Myskowski, P.; Hancock, H.; Davey, T.; Obadi, O.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • Long-term sustained minimal residual disease (MRD) negativity in multiple myeloma patients treated with lenalidomide maintenance therapy: A clinical and correlative phase 2 study
    Meeting Abstract

    Landgren, O.; Mastey, D.; Lesokhin, A. M.; Smith, E. L.; Shah, U. A.; Mailankody, S.; Hultcrantz, M.; Hassoun, H.; Lu, S. X.; Salcedo, M.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • Incidence of delayed seromas and related risk of BIA-ALCL in a cohort of 3521 breast cancer women with textured implants prospectively followed long term
    Meeting Abstract

    Ghione, P.; Cordeiro, P.; Seshan, V.; Galasso, N.; Ganesan, N.; Hu, Q.; Dogan, A.; Horwitz, S. M.
    Blood (2019)

    Fulltext@MSK | Save
  • Contemporary outcomes in HTLV-1-associated adult T-cell leukemia/lymphoma: Single-institution experience
    Meeting Abstract

    Epstein-Peterson, Z. D.; Ghione, P.; Moskowitz, A. J.; Dahi, P. B.; Dogan, A.; Kumar, A.; Matasar, M. J.; Noy, A.; Perales, M. A.; Ponce, D. M.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • CD4 lymphocytes and T regulatory cells show distinct phenotypes in follicular lymphoma and classical Hodgkin lymphoma which may account for differences in responses to checkpoint therapy
    Meeting Abstract

    El Daker, S.; Gao, Q.; Roshal, M.; Dogan, A.
    Blood (2019)

    Fulltext@MSK | Save
  • Central nervous system prophylaxis with high-dose intravenous methotrexate or intrathecal chemotherapy in patients with diffuse large B-cell lymphoma and high-risk of CNS relapse treated in the rituximab era
    Meeting Abstract

    Bobillo, S.; Joffe, E.; Seshan, V.; Noy, A.; Horwitz, S. M.; Palomba, M. L.; Matasar, M. J.; Straus, D. J.; Hamlin, P. A.; Batlevi, C. L.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • First description of B cell maturation antigen expression in light chain amyloidosis
    Meeting Abstract

    Bal, S.; Sigler, A.; Chan, A.; Chung, D. J.; Dogan, A.; Giralt, S. A.; Hassoun, H.; Landau, H. J.
    Blood (2019)

    Fulltext@MSK | Save
  • Weekly carfilzomib, lenalidomide, dexamethasone and daratumumab (wKRd-D) combination therapy provides unprecedented MRD negativity rates in newly diagnosed multiple myeloma: A clinical and correlative phase 2 study
    Meeting Abstract

    Landgren, O.; Hultcrantz, M.; Lesokhin, A. M.; Mailankody, S.; Hassoun, H.; Smith, E. L.; Shah, U. A.; Lu, S. X.; Mastey, D.; Salcedo, M.; more...
    Blood (2019)

    Fulltext@MSK | Save